The 2018 Farm Bill pulled hemp from the Controlled Substances Act, legalizing its cultivation and production, but complications linger.
To fully comply with this landmark legislation, manufacturers must guarantee that any hemp-derived CBD built into their products are grown only by U.S. farmers in states with formal hemp programs. There is a legitimate risk that manufacturers and distributors might find themselves unwittingly purchasing and transporting a Schedule 1 substance if they lack full transparency and traceability of the source of their CBD products.
Needless to say, the hemp-derived CBD category is experiencing explosive expansion and the market opportunities are enormous – and still virtually untapped. But what is the regulatory path going forward with so many questions still unanswered? More is known about the don’ts, but there are obvious – and less-obvious – dos to consider.
“Although global hemp industry regulations remain uncertain, everyone working in hemp today recognizes the need for additional standardization, to support imminent compliance requirements.” – Gary Nowacki, TraceGains CEO
This webinar will explore the landscape surrounding the development of Good Manufacturing Practices (GMP) standards.
This on-demand webinar will show: